X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5367) 5367
Newsletter (440) 440
Publication (288) 288
Book Review (96) 96
Newspaper Article (27) 27
Book Chapter (16) 16
Dissertation (16) 16
Magazine Article (15) 15
Conference Proceeding (10) 10
Trade Publication Article (4) 4
Paper (3) 3
Web Resource (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
quetiapine (3732) 3732
humans (3419) 3419
psychiatry (2541) 2541
quetiapine fumarate (2338) 2338
male (2091) 2091
antipsychotic agents - therapeutic use (2087) 2087
female (1910) 1910
index medicus (1804) 1804
adult (1616) 1616
schizophrenia (1582) 1582
antipsychotic agents - adverse effects (1470) 1470
dibenzothiazepines - therapeutic use (1459) 1459
pharmacology & pharmacy (1449) 1449
olanzapine (1406) 1406
risperidone (1248) 1248
middle aged (1175) 1175
schizophrenia - drug therapy (1021) 1021
double-blind (1017) 1017
dibenzothiazepines - adverse effects (963) 963
treatment outcome (897) 897
clinical neurology (820) 820
neurosciences (776) 776
clozapine (771) 771
bipolar disorder (761) 761
aged (658) 658
adolescent (647) 647
atypical antipsychotics (646) 646
antipsychotic agents - administration & dosage (645) 645
haloperidol (632) 632
drug therapy (598) 598
bipolar disorder - drug therapy (588) 588
antipsychotics (572) 572
risperidone - therapeutic use (526) 526
efficacy (510) 510
research (510) 510
aripiprazole (504) 504
antipsychotic drugs (498) 498
benzodiazepines - therapeutic use (476) 476
dibenzothiazepines - administration & dosage (460) 460
drug therapy, combination (443) 443
drugs (443) 443
care and treatment (437) 437
psychotic disorders - drug therapy (427) 427
dose-response relationship, drug (420) 420
psychotropic drugs (399) 399
analysis (394) 394
antipsychotic agents - pharmacology (387) 387
young adult (386) 386
psychiatric status rating scales (375) 375
risperidone - adverse effects (358) 358
double-blind method (357) 357
dosage and administration (337) 337
neuroleptics (333) 333
depression (321) 321
antidepressants (317) 317
risk factors (316) 316
placebo (313) 313
animals (311) 311
benzodiazepines - adverse effects (299) 299
ziprasidone (291) 291
dibenzothiazepines - pharmacology (286) 286
piperazines - therapeutic use (286) 286
psychosis (285) 285
psychology, clinical (280) 280
mental disorders (278) 278
placebo-controlled trial (274) 274
medicine & public health (256) 256
retrospective studies (255) 255
medical research (251) 251
clinical trials (250) 250
lithium (250) 250
time factors (246) 246
schizophrenic psychology (245) 245
drug administration schedule (241) 241
disorder (237) 237
medicine, experimental (231) 231
clozapine - therapeutic use (226) 226
randomized controlled trials as topic (211) 211
antipsychotic (206) 206
quetiapine fumarate - therapeutic use (206) 206
rating-scale (206) 206
risk (206) 206
child (205) 205
severity of illness index (205) 205
thiazoles - therapeutic use (203) 203
health aspects (201) 201
antidepressive agents - therapeutic use (200) 200
major depressive disorder (200) 200
mania (197) 197
medicine, general & internal (189) 189
complications and side effects (187) 187
internal medicine (186) 186
pharmacotherapy (185) 185
dementia (184) 184
children (183) 183
comorbidity (182) 182
pharmacokinetics (182) 182
aged, 80 and over (179) 179
safety (179) 179
prevalence (178) 178
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5475) 5475
German (91) 91
Turkish (77) 77
Spanish (47) 47
Italian (29) 29
French (22) 22
Japanese (19) 19
Polish (19) 19
Hungarian (18) 18
Russian (18) 18
Portuguese (15) 15
Dutch (14) 14
Czech (9) 9
Chinese (8) 8
Korean (6) 6
Danish (5) 5
Bosnian (2) 2
Hebrew (2) 2
Norwegian (2) 2
Croatian (1) 1
Greek (1) 1
Lithuanian (1) 1
Romanian (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychiatric Times, ISSN 0893-2905, 11/2018, Volume 35, Issue 11, p. 3
Journal Article
Anaesthesia, ISSN 0003-2409, 02/2009, Volume 64, Issue 2, p. 191
We describe the initial management and subsequent recovery of a 61 year-old male patient following attempted suicide by oral ingestion of a potentially fatal... 
Quetiapine
Journal Article
The Brown University Psychopharmacology Update, ISSN 1068-5308, 11/2014, Volume 25, Issue 11, p. 7
Journal Article
Journal Article
European Psychiatry, ISSN 0924-9338, 04/2017, Volume 41, pp. S434 - S434
This case report describes the successful use of low dose quetiapine in the treatment of agitation in a patient with Treacher-Collins syndrome (TCS) and... 
Usage | Quetiapine
Journal Article
Environmental Pollution, ISSN 0269-7491, 11/2016, Volume 218, pp. 66 - 76
The antipsychotic drug quetiapine (QUT) has been frequently detected in sewage treatment plants. However, information on the fate of QUT in aquatic... 
Umu-test | Closed Bottle Test (CBT) | Quetiapine carboxylic acid | High-resolution mass spectrometry | Manometric Respirometry Test (MRT) | Luminescent bacteria test | TOXICITY | TRANSFORMATION PRODUCTS | TANDEM MASS-SPECTROMETRY | IDENTIFICATION | HOSPITAL WASTE-WATER | ENVIRONMENTAL SCIENCES | WATER TREATMENT PLANTS | PSYCHOACTIVE PHARMACEUTICALS | PHOTODEGRADATION | DEGRADATION | Antipsychotic Agents - radiation effects | Antipsychotic Agents - toxicity | Quetiapine Fumarate - analysis | Humans | Quetiapine Fumarate - metabolism | Biological Oxygen Demand Analysis | Quetiapine Fumarate - radiation effects | Ultraviolet Rays | Photolysis | Biotransformation | Mass Spectrometry | Water Pollutants, Chemical - radiation effects | Salmonella typhimurium - drug effects | Biodegradation, Environmental | Salmonella typhimurium - genetics | Microbial Viability | Quetiapine Fumarate - toxicity | Water Pollutants, Chemical - analysis | Water Pollutants, Chemical - metabolism | Water Pollutants, Chemical - toxicity | Aliivibrio fischeri - drug effects | Antipsychotic Agents - analysis | Rivers - chemistry | Antipsychotic Agents - metabolism | Rivers - microbiology | Toxicity Tests | Water Purification - methods | Germany | Bacteria | Sewage | Purification | Mass spectrometry | Quetiapine | Green technology | Product introduction | Index Medicus
Journal Article
Journal Article
ANZ Journal of Surgery, ISSN 1445-1433, 07/2019, Volume 89, Issue 7-8, pp. E335 - E336
Journal Article
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, ISSN 0004-8674, 09/2017, Volume 51, Issue 9, pp. 939 - 940
Journal Article
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2018, Volume 235, Issue 1, pp. 245 - 255
The use of second-generation antipsychotics (SGA) has been associated with metabolic changes. However, there are differences in the metabolic profile between... 
Medication-naïve | Neurosciences | Biomedicine | Second-generation antipsychotic | Triglycerides | Glucose | Pharmacology/Toxicology | Psychiatry | Weight gain | Cholesterol | CARDIOMETABOLIC RISK | PSYCHIATRY | SCHIZOAFFECTIVE DISORDER | OPEN-LABEL | CHRONIC-SCHIZOPHRENIA | RISPERIDONE | NEUROSCIENCES | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | WEIGHT-GAIN | 1ST TREATED EPISODE | OLANZAPINE | Medication-naive | ANTIPSYCHOTIC MEDICATIONS | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Body Weight - drug effects | Male | Thiazoles - therapeutic use | Thiazoles - adverse effects | Aripiprazole - adverse effects | Young Adult | Dibenzothiazepines - therapeutic use | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Aripiprazole - therapeutic use | Adult | Female | Quetiapine Fumarate - pharmacology | Body Mass Index | Quetiapine Fumarate - adverse effects | Piperazines - therapeutic use | Cholesterol - metabolism | Piperazines - adverse effects | Piperazines - pharmacology | Quetiapine Fumarate - therapeutic use | Triglycerides - metabolism | Blood Glucose - drug effects | Psychotic Disorders - metabolism | Aripiprazole - pharmacology | Psychotic Disorders - drug therapy | Thiazoles - pharmacology | Antipsychotic Agents - pharmacology | Drugs | Lipoproteins (low density) | Obesity | Neuroleptics | Mental disorders | Ziprasidone | Clinical trials | Aripiprazole | Metabolism | Patients | Psychosis | Psychotropic drugs | Hypercholesterolemia | Body mass | Hypertriglyceridemia | Psychopharmacology | Lipoproteins (high density) | Quetiapine
Journal Article